Immunomodulation: a new horizon for medical treatment of heart failure

Journal of Cardiac Failure
Shigetake SasayamaC Kishimoto

Abstract

Recently, the intriguing possibility has been raised that heart failure may be mediated by the biological effects of cytokines. Indeed, we found elevation of plasma concentrations of various cytokines in patients with myocardial disease. We also detected positive tumor necrosis factor (TNF-alpha) immunoreactivity in right atrial tissues obtained during surgery from patients with severe heart failure. Therefore, we postulated that some aspects of heart failure may be related to non-lethal down-modulation of cardiac function by immune cells and their cytokines. Testing this hypothesis in an experimental model of murine myocarditis, we found that injection of recombinant human TNF-alpha increased mortality of the animals infected with myocarditis virus. The anti-TNF-alpha monoclonal antibody improved survival and attenuated the myocardial lesions. Whereas, administration of recombinant human IL-2 in the acute viremic stage increased survival rate, and resulted in less intense pathological changes in the myocardium while in the subacute aviremic stage, the same amount of IL-2 reduced survival rate and exacerbated severity of the disease. Therefore, cytokine release may initiate a beneficial inflammatory and immune response in the a...Continue Reading

References

Feb 1, 1992·Cardiovascular Drugs and Therapy·S Sasayama
Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Nov 1, 1995·Circulation·A MatsumoriS Sasayama
Dec 1, 1994·British Heart Journal·A MatsumoriS Sasayama
May 1, 1994·Circulation·W H Barry
Feb 1, 1994·Circulation Research·T A MartinoM J Sole
Dec 1, 1995·Journal of Cardiac Failure·S Sasayama

❮ Previous
Next ❯

Citations

May 20, 1998·Journal of Clinical Pharmacology·S Anandasabapathy, W H Frishman
Sep 5, 2001·International Journal of Cardiology·D J van Veldhuisen, P A Poole-Wilson
Jan 26, 2000·International Journal of Cardiology·R SharmaS D Anker
Feb 1, 2002·Congestive Heart Failure·Rakesh Sharma, Stefan D Anker
Jan 29, 2008·Current Treatment Options in Cardiovascular Medicine·William H FrishmanNauman Naseer
Sep 12, 2000·Current Cardiology Reports·L Vadlamani, W T Abraham
Mar 9, 2002·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·A Raynaud-SimonY Le Bouc
Jun 12, 1999·Journal of the American Geriatrics Society·L FerrucciR J Havlik
May 25, 2002·Heart Disease·William H FrishmanSharmila Anandasabapathy
May 16, 2002·Journal of Cellular Physiology·Antonio De MaioJorge E Contreras
Jul 11, 2003·Anti-cancer Drugs·Hitoshi KawamataTakahiro Fujimori
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S K Manna, B B Aggarwal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.